Eisai Co, Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It develops Fycompa, an antiepileptic drug in the neurology area that is approved as an adjunctive therapy for partial-onset seizures in Japan, the United States, Europe, and Asia. The company is also approved for use as monotherapy for the treatment of partial onset seizures in the United States; and as an adjunctive therapy for primary generalized tonic-clonic seizures in Japan, the United States, Europe, and Asia.
Read More…
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorMedical
Phone813-3817-3700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$5.42 billion
Profitability
Miscellaneous
Employees10,456
Next Earnings Date8/21/2019 (Estimated)
OptionableNot Optionable
Eisai (OTCMKTS:ESALY) Frequently Asked Questions
What is Eisai's stock symbol?
Eisai trades on the OTCMKTS under the ticker symbol "ESALY."
When is Eisai's next earnings date?
What guidance has Eisai issued on next quarter's earnings?
Eisai updated its FY 2019 earnings guidance on Wednesday, July, 31st. The company provided earnings per share guidance of $2.31-2.31 for the period. The company issued revenue guidance of $6.256-6.256 billion.
What is the consensus analysts' recommendation for Eisai?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last year. There are currently 2 sell ratings and 1 hold rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Eisai.
Has Eisai been receiving favorable news coverage?
Media stories about ESALY stock have been trending negative on Monday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eisai earned a daily sentiment score of -2.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Eisai.
Who are some of Eisai's key competitors?
Some companies that are related to Eisai include Recruit (RCRRF), BK COMMUNICATIO/ADR (BCMXY), PERNOD RICARD S/ADR (PDRDY), ORIENTAL LD CO/ADR (OLCLY), SHIN ETSU CHEM/ADR (SHECY), SCHNEIDER ELEC /ADR (SBGSY), Sun Hung Kai Properties (SUHJY), SWATCH GRP AG/ADR (SWGAY), COMPASS GRP PLC/S (CMPGY), SWIRE PAC LTD/S (SWRAY), Bayerische Motoren Werke (BAMXF), DEUTSCHE POST A/S (DPSGY), Muenchener Ruckvrschrg Gslcht AG Mch (MURGY), China Shenhua Energy (CSUAY) and JAPAN TOB INC/ADR (JAPAY).
What other stocks do shareholders of Eisai own?
Who are Eisai's key executives?
Eisai's management team includes the folowing people:
- Mr. Haruo Naito, CEO, Representative Corp. Officer & Director (Age 72)
- Mr. Gary Hendler, Sr. VP & Pres of EMEA Region (Age 53)
- Dr. Lynn D. Kramer, VP and Chief Clinical Officer & Chief Medical Officer - Neurology Bus. Group (Age 69)
- Mr. Alexander Scott, VP, Chief Strategy Officer & Head of Strategy Dept. - Neurology Bus. Group
- Ms. Shaji Procida, VP and Pres & COO of Eisai Inc. (Age 48)
How do I buy shares of Eisai?
Shares of ESALY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Eisai's stock price today?
One share of ESALY stock can currently be purchased for approximately $50.73.
How big of a company is Eisai?
What is Eisai's official website?
How can I contact Eisai?
Eisai's mailing address is 4-6-10 Koishikawa Bunkyo-ku, Tokyo M0, 112-8088. The company can be reached via phone at 813-3817-3700.
MarketBeat Community Rating for Eisai (OTCMKTS ESALY)
MarketBeat's community ratings are surveys of what our community members think about Eisai and other stocks. Vote "Outperform" if you believe ESALY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESALY will underperform the S&P 500 over the long term. You may vote once every thirty days.
